50m
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CVS Health (CVS – Research Report) and ...
RBC Capital analyst Luca Issi maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) yesterday and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback